Rapid molecular testing in bloodstream infections: Improving patient outcomes, reducing health care costs, and aiding clinical pharmacists in decision making

U.S. Pharmacist

Volumn 34, Issue 9, 2009, Pages

  Beyda, Nicholas D ^a   Eiland III, Edward H ^b  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b HUNTSVILLE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; PEPTIDE NUCLEIC ACID; RNA 16S; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; BLOODSTREAM INFECTION; CANDIDA ALBICANS; CLINICAL PHARMACY; COAGULASE NEGATIVE STAPHYLOCOCCUS; COST EFFECTIVENESS ANALYSIS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SENSITIVE STAPHYLOCOCCUS AUREUS; MULTIPLEX POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS;

EID: 73649147053     PISSN: 01484818     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (19)

1. Kollef MH, Napolitano LM, Solomkin JS. Health care associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI summit. Clin Infect Dis. 2008;47(suppl 2):S55-S99.
2. Minino AM, Smith BL. Deaths: preliminary data for 2000. Natl Vital Stat Rep. 2001;49:1-40.
3. Diekema DJ, Beekmann SE, Chapin KC, et al. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol. 2003;41:3655-3660.
4. Shorr AF, Tabak YP, Killian AD, et al. Healthcare-associated bloodstream infection: a distinct entity? Insights from a large U.S. database. Crit Care Med. 2006;34:2588-2595.
5. Khatib R, Saeed S, Sharma M, et al. Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis. 2006;25:181-185.
6. Espy MJ, Uhl JR, Sloan LM, et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev. 2006;19:165-256.
7. Lehmann LE, Hunfeld KP, Emrich T, et al. A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med Microbiol Immunol. 2008;197:313-324.
8. Tang Y, Kilic A, Yang Q, et al. StaphPlex system for rapid and simultaneous identification of antibiotic resistance determinants and Panton-Valentine leukocidin detection of Staphylococci from positive blood cultures. J Clin Microbiol. 2007;45:1867-1873.
9. Procop GW. Molecular diagnostics for the detection and characterization of microbial pathogens. Clin Infect Dis. 2007;45(suppl 2):S99-S111.
10. Forrest GN, Mehta S, Weekes E, et al. Impact of in situ hybridization on coagulase-negative staphylococci positive blood cultures. J Antimicrob Chemother. 2006;58:154-158.
11. Forrest GN, Mankes K, Jabra-Rizk MA, et al. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J Clin Microbiol. 2006;44:3381-3383.
12. Ly T, Gulia J, Pyrgos V. Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time. Ther Clin Risk Manag. 2008;4:637-640.
13. Forrest GN, Roghmann MC, Toombs LS, et al. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob Agents Chemother. 2008;52:3558-3563.
14. De Rijdt, Willems L, Simoens S. Economic effects of clinical pharmacy interventions: a literature review. Am J Health Syst Pharm. 2008;65:1161-1172.
15. Tonna AP, Stewart D, West B, et al. Antimicrobial optimization in secondary care: the pharmacist as part of a multidisciplinary antimicrobial programme - a literature review. Int J Antimicrob Agents. 2008;31:511-517.
16. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-177.
17. Carver PL, Lin S, DePestel DD, Newton DW. Impact of mecA gene testing and intervention by infectious disease clinical pharmacists on time to optimal antimicrobial therapy for Staphylococcus aureus bacteremia at a university hospital. J Clin Microbiol. 2008;46:2381-2383.
18. Lodise TP, McKinnon PS, Swiderski L, Rybak, MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis. 2003;36:1418-1423.
19. Klouche M, Schroder U. Rapid methods for diagnosis of bloodstream infections. Clin Chem Lab Med. 2008;46:888-908.